Prospective, Multicenter, Randomized Phase III Trial Evaluating the Impact of Lymphoscintigraphy as Part of Sentinel Node Biopsy in Early Breast Cancer: SenSzi (GBG80) Trial

Author:

Kuemmel Sherko1,Holtschmidt Johannes1,Gerber Bernd2,Von der Assen Albert3,Heil Joerg4,Thill Marc5,Krug David4,Schem Christian67,Denkert Carsten8,Lubitz Juliane1,Blohmer Jens Uwe9,Reinisch Mattea110,Hötzeldt Michael11,Seither Fenja10,Nekljudova Valentina10,Schwidde Ilka12,Uhrhan Klara13,Von Minckwitz Gunter10,Rezai Mahdi14,Mulowski Jana1,Loibl Sibylle10,Kuehn Thorsten15

Affiliation:

1. Kliniken Essen-Mitte, Essen, Germany

2. University of Rostock, Rostock, Germany

3. Niels-Stensen-Kliniken, Georgsmarienhütte, Germany

4. University Hospital Heidelberg, Heidelberg, Germany

5. Agaplesion Markus Krankenhaus, Frankfurt, Germany

6. University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany

7. Mammazentrum Hamburg, Hamburg, Germany

8. Charité Universitätsmedizin Berlin, Berlin, Germany

9. Breast Center of the Charité, Berlin, Germany

10. German Breast Group, Neu-Isenburg, Germany

11. Brustzentrum Asklepios Harzklinik, Goslar, Germany

12. Die Frauenärztinnen Mülheim an der Ruhr, Mülheim, Germany

13. Zentrum für Nuklearmedizin und Molekulare Bildgebung Essen, Essen, Germany

14. Luisenkrankenhaus Düsseldorf, Düsseldorf, Germany

15. Clinic Esslingen, Esslingen, Germany

Abstract

PURPOSE The aim of the current work was to clarify whether a preoperative lymphoscintigraphy (LSG) enhances staging accuracy of sentinel lymph node biopsy (SLNB). PATIENTS AND METHODS In a prospective, multicenter, randomized phase III trial, patients with cN0 early breast cancer or extensive/high-grade ductal carcinoma in situ planned for standard radioactive-labeled colloid LSG with subsequent SLNB were randomly assigned 1:1 to receive SLNB either with knowledge of the LSG findings or without. As the false-negative rate of SLNB correlates with the number of resected sentinel lymph nodes (SLNs), our primary end point was the mean number of histologically detected SLNs per patient. One thousand one hundred two evaluable patients were necessary to demonstrate noninferiority of SLNB without LSG. Stratified one-sided 95% CI for the difference (without LSG − with LSG) in the mean number of histologically detected SLNs had to be greater than −0.27 (10% noninferiority margin). Stratification was performed according to tumor focality and trial site. Additional predefined secondary end points (rates of node-positive patients and of completion axillary lymph node dissection) were analyzed to rule out differences in the reliable detection of nodal metastases. RESULTS Between May 2014 and October 2015, 1,198 patients were randomly assigned in 23 German and Swiss breast centers. Modified intention-to-treat analysis (n = 1,163) showed a mean number of histologically detected SLNs of 2.21 with LSG and 2.26 without LSG (difference 0.05; stratified 95% CI, −0.18 to infinity), thus establishing noninferiority of omitting preoperative LSG. Secondary end points displayed no statistically significant differences. CONCLUSION We show that SLNB is equally effective irrespective of the surgeon’s knowledge of preoperative LSG results. SLNB without LSG will speed up the preoperative workflow and reduce cost.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3